SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Atlas Venture Opportunity Fund I, L.P., a major early investor, filed a…

Dyne Therapeutics, Inc. · 144 filed Jun 26, 2026 at 17:04 ET

At the news

NEUTRALIMPACT 3/10

144 filed Jun 26, 2026 at 17:04 ET

Atlas Venture Opportunity Fund I, L.P., a major early investor, filed a Form 144 notice of intent to sell 64,411 shares of Dyne Therapeutics common stock, valued at approximately $1.33M at the filing date. This represents a routine insider sale by a pre-IPO venture backer and does not signal a change in company outlook.

  • Atlas Venture Opportunity Fund I, L.P. filed Form 144 to sell 64,411 shares of Dyne Therapeutics common stock.
  • The estimated market value of the proposed sale is approximately $1.33 million.
  • The shares were acquired in a private placement on August 7, 2020.
  • The insider has sold no other securities in the past 3 months.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access